Skip to main content
Erschienen in: Sleep and Breathing 1/2022

29.04.2021 | Sleep Breathing Physiology and Disorders • Editorial

Scleroderma and obstructive sleep apnea: a consideration of immunological aspects and the role of fibrosis

verfasst von: Ellen M. S. Xerfan, Anamaria S. Facina, Jane Tomimori, Sandra D. Xavier, Sergio Tufik, Monica L. Andersen

Erschienen in: Sleep and Breathing | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Sleep disorders are known to be related to autoimmune diseases due to the inflammatory and immunological imbalance induced by or aggravating poor sleep [1]. In this context, we are writing to discuss a relationship that needs to be more clearly understood, that between obstructive sleep apnea (OSA)—a widely prevalent sleep breathing disorder [2]—and scleroderma—an autoimmune disease that can affect breathing through a number of mechanisms, including lung fibrosis. We highlight pathological and immunological features that both diseases might have in common, and which warrant further clarification. …
Literatur
1.
Zurück zum Zitat Nokes BT, Raza HA, Cartin-Ceba R, Lyng PJ, Krahn LE, Wesselius L, Jokerst CE, Umar SB, Griffing WL, Neville MR, Malhotra A, Parish JM (2019) Individuals with scleroderma may have increased risk of sleep-disordered breathing. J Clin Sleep Med 15:1665–1669CrossRef Nokes BT, Raza HA, Cartin-Ceba R, Lyng PJ, Krahn LE, Wesselius L, Jokerst CE, Umar SB, Griffing WL, Neville MR, Malhotra A, Parish JM (2019) Individuals with scleroderma may have increased risk of sleep-disordered breathing. J Clin Sleep Med 15:1665–1669CrossRef
2.
Zurück zum Zitat Tufik S, Santos-Silva R, Taddei JA, Bittencourt LRA (2010) Obstructive sleep apnea syndrome in the Sao Paulo epidemiologic sleep study. Sleep Medicine 11:441–446CrossRef Tufik S, Santos-Silva R, Taddei JA, Bittencourt LRA (2010) Obstructive sleep apnea syndrome in the Sao Paulo epidemiologic sleep study. Sleep Medicine 11:441–446CrossRef
3.
Zurück zum Zitat Artlett CM (2018) The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis? Immunol Lett 195:30–37CrossRef Artlett CM (2018) The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis? Immunol Lett 195:30–37CrossRef
4.
Zurück zum Zitat Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA (2009) Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 136:772–778CrossRef Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA (2009) Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 136:772–778CrossRef
5.
Zurück zum Zitat Pihtili A, Bingol Z, Kiyan E, Cuhadaroglu C, Issever H, Gulbaran Z (2013) Obstructive sleep apnea is common in patients with interstitial lung disease. Sleep Breath 17:1281–1288CrossRef Pihtili A, Bingol Z, Kiyan E, Cuhadaroglu C, Issever H, Gulbaran Z (2013) Obstructive sleep apnea is common in patients with interstitial lung disease. Sleep Breath 17:1281–1288CrossRef
6.
Zurück zum Zitat Young IH, Bye PT (2011) Gas exchange in disease: asthma, chronic obstructive pulmonary disease, cystic fibrosis, and interstitial lung disease. Compr Physiol. 1:663–697CrossRef Young IH, Bye PT (2011) Gas exchange in disease: asthma, chronic obstructive pulmonary disease, cystic fibrosis, and interstitial lung disease. Compr Physiol. 1:663–697CrossRef
7.
Zurück zum Zitat Myall KJ, West A, Kent BD (2019) Sleep and interstitial lung disease. Curr Opin Pulm Med 25:623–628CrossRef Myall KJ, West A, Kent BD (2019) Sleep and interstitial lung disease. Curr Opin Pulm Med 25:623–628CrossRef
8.
Zurück zum Zitat Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667CrossRef Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667CrossRef
9.
Zurück zum Zitat Gabryelska A, Kuna P, Antczak A, Białasiewicz P, Panek M (2019) IL-33 Mediated inflammation in chronic respiratory diseases – understanding the role of the member of IL-1 superfamily. Front Immunol 10:692CrossRef Gabryelska A, Kuna P, Antczak A, Białasiewicz P, Panek M (2019) IL-33 Mediated inflammation in chronic respiratory diseases – understanding the role of the member of IL-1 superfamily. Front Immunol 10:692CrossRef
10.
Zurück zum Zitat Carpagnano GE, Spanevello A, Sabato R, Depalo A, Palladino GP, Bergantino L, Foschino Barbaro MP (2010) Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8. Transl Res 155:35–43CrossRef Carpagnano GE, Spanevello A, Sabato R, Depalo A, Palladino GP, Bergantino L, Foschino Barbaro MP (2010) Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8. Transl Res 155:35–43CrossRef
Metadaten
Titel
Scleroderma and obstructive sleep apnea: a consideration of immunological aspects and the role of fibrosis
verfasst von
Ellen M. S. Xerfan
Anamaria S. Facina
Jane Tomimori
Sandra D. Xavier
Sergio Tufik
Monica L. Andersen
Publikationsdatum
29.04.2021
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 1/2022
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-021-02324-0

Weitere Artikel der Ausgabe 1/2022

Sleep and Breathing 1/2022 Zur Ausgabe

Sleep Breathing Physiology and Disorders • Original Article

Metabolic outcomes in adults with type 2 diabetes and sleep disorders

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.